Table 1 Selected real world clinical studies of Saroglitazar
Group | Study duration | Number of studies | Selected studies |
|---|---|---|---|
Group 1 | 12 weeks | 4 | Shetty et al. [13], Thacker et al. [14], Joshi et al. [15], Bhattacharyya et al. [16] |
Group 2 | 24 weeks | 6 | Saboo et al. [17], Joshi et al. [18], Chhaya et al. [19], Mohit et al. [20], Kaul et al. [21], Goyal et al. [22] |
Group 3 | 27 weeks | 1 | Chatterjee et al. [23] |
Group 4 | 36 weeks | 1 | Joshi et al. [24] |
Group 5 | 40 weeks | 1 | Chatterjee et al. [25] |
Group 6 | 52 weeks | 4 | Joshi et al. [26], Aneja et al. [27], Maheshwari et al. [28], Chatterjee et al. [29] |
Group 7 | 58 weeks | 1 | Chatterjee et al. [30] |